Ambea Year-end Report January–December 2025

Ambea reported continued growth driven by acquisitions with Q4 net sales up 15% to SEK 4,193m (organic +4%, acquired +13%) and full-year sales up 13% to SEK 16,039m; full-year EBIT rose to SEK 1,379m and EBITA to SEK 1,455m (margin 9.1%), while Q4 EBITA margin compressed to 7.8%. The group generated strong free cash flow (Q4 SEK 881m; FY SEK 2,052m), proposed an increased dividend of SEK 2.65 per share and announced a supplemental buyback program of up to two million shares; growth initiatives include acquisitions in Finland (total annual sales > SEK 200m) and Sweden (Nytida acquisition SEK 45m). Management highlights strategic investments in leadership training, a Nordic quality management system and IT security/scalability, while some units (Stendi) showed weaker quarterly performance, underpinning a cautiously positive outlook for 2026 execution.

Analysis

Market structure: Ambea (Stockholm-listed Nordic care operator) and other scale players win — acquisitions add >SEK 200m annual revenue in Finland and SEK 45m in Sweden, expanding addressable market and procurement/negotiation leverage with municipalities. Small, single-unit operators and loss-making regional chains are losers as Ambea leverages centralised IT, quality systems and leadership training to pursue margin recovery; expect modest pricing power for standard care contracts but stronger win-rate in specialised social-care niches.

Risk assessment: Key tail risks are regulatory reversals in Finland/Sweden, integration failure of recent acquisitions (control transfer 31 Jan 2026), and sustained wage inflation compressing EBITA below 8% (current FY EBITA margin 9.1%, Q4 7.8%). Near-term (days–weeks) focus is on the conference call and buyback details; medium-term (3–12 months) risk is execution on synergies and occupancy in new units; long-term (1–3 years) upside hinges on successful Nordic quality/IT rollout and stable public funding.

Trade implications: Construct a 6–12 month core long (2–3% portfolio) in Ambea ahead of buyback execution and FY+dividend momentum, using a protective 12-month 15% OTM put to cap downside; sell 1–3 month 5% OTM covered calls to enhance yield while awaiting catalysts. Relative trade: long Ambea vs short a small-cap local care operator with weak balance sheet (size-match ~1:1 revenue exposure) to capture consolidation spread. If volatility rises, prefer buy-call-spreads 12 months out (buy 25% OTM, sell 50% OTM) rather than naked calls.

Contrarian angles: The market underestimates integration and staffing risk — a successful buyback (max 2m shares) is likely immaterial EPS-wise versus SEK 2,052m free cash flow, so any rally may be short-lived absent margin recovery. Historical parallels: Nordic care consolidations show 6–12 month margin compression then recovery; if Ambea misses occupancy or margins drop <8% sustainably, reassess and consider trimming on a 15–25% rally or add to shorts.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in Ambea (Stockholm-listed Nordic care operator) within 1–4 weeks to capture acquisition-led revenue growth and proposed dividend (SEK 2.65), size position to target 12-month IRR of 10–15%; place a stop-loss at 15% below entry.
• Hedge the long with a 12-month protective put ~15% OTM (cost-funded by selling 3–6 month 5% OTM covered calls) to limit downside while collecting premium ahead of buyback/call.
• Implement a relative-value pair trade: long Ambea vs short a smaller, financially constrained Nordic care operator (~1:1 revenue exposure) for a 3–9 month horizon to exploit consolidation advantages; target 5–10% absolute spread capture.
• Use options if volatility rises: buy 12-month call spreads (buy 25% OTM, sell 50% OTM) sized to 1–1.5% portfolio for asymmetric upside exposure; avoid naked premium-selling given staffing/regulatory tail risk.
• Monitor three catalysts for re-rating over next 60 days: details/timing of the share buyback execution, results of the Jan 31, 2026 Finnish control transfer, and Q1 2026 margin trajectory; trim on a 15–25% rally or if EBITA margin falls below 8% for two consecutive quarters.